{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:04:49Z","timestamp":1792065889681,"version":"4.4.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>\n                    12\/15-LO (12\/15-lipoxygenase), encoded by\n                    <jats:italic>Alox15<\/jats:italic>\n                    gene, metabolizes arachidonic acid to 12(S)-HETE (12-hydroxyeicosatetraenoic acid). Macrophages are the major source of 12\/15-LO among immune cells, and 12\/15-LO plays a crucial role in development of hypertension. Global\n                    <jats:italic>Alox15<\/jats:italic>\n                    - or macrophage-deficient mice are resistant to Ang II (angiotensin II)\u2013induced hypertension. This study tests the hypothesis that macrophage 12(S)-HETE contributes to Ang II\u2013mediated arterial constriction and thus to development of Ang II\u2013induced hypertension. Ang II constricted isolated abdominal aortic and mesenteric arterial rings. 12(S)-HETE (100 nmol\/L) alone was without effect; however, it significantly enhanced Ang II\u2013induced constriction. The presence of wild-type macrophages also enhanced the Ang II\u2013induced constriction, while\n                    <jats:italic>\n                      Alox15\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    <\/jats:italic>\n                    macrophages did not. Using this model, pretreatment of aortic rings with inhibitors, receptor agonists\/antagonists, or removal of the endothelium, systematically uncovered an endothelium-mediated, Ang II receptor-2\u2013mediated and superoxide-mediated enhancing effect of 12(S)-HETE on Ang II constrictions. The role of superoxide was confirmed using aortas from\n                    <jats:italic>\n                      p47\n                      <jats:sup>phox\u2212\/\u2212<\/jats:sup>\n                    <\/jats:italic>\n                    mice where 12(S)-HETE failed to enhance constriction to Ang II. In cultured arterial endothelial cells, 12(S)-HETE increased the production of superoxide, and 12(S)-HETE or Ang II increased the production of an isothromboxane-like metabolite. A TP (thromboxane receptor) antagonist inhibited 12(S)-HETE enhancement of Ang II constriction. Both Ang II\u2013induced hypertension and the enhancing effect of 12(S)-HETE on Ang II contractions were eliminated by a BLT2 (leukotriene B\n                    <jats:sub>4<\/jats:sub>\n                    receptor-2) antagonist. These results outline a mechanism where the macrophage 12\/15-LO pathway enhances the action of Ang II. 12(S)-HETE, acting on the BLT2, contributes to the hypertensive action of Ang II in part by promoting endothelial synthesis of a superoxide-derived TP agonist.\n                  <\/jats:p>","DOI":"10.1161\/hypertensionaha.121.17824","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T05:01:24Z","timestamp":1637125284000},"page":"104-114","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Macrophage 12(S)-HETE Enhances Angiotensin II\u2013Induced Contraction by a BLT2 (Leukotriene B\n                    <sub>4<\/sub>\n                    Type-2 Receptor) and TP (Thromboxane Receptor)-Mediated Mechanism in Murine Arteries"],"prefix":"10.1161","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7937-0076","authenticated-orcid":true,"given":"Tamas","family":"Kriska","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee (T.K., A.H., S.L.P., W.B.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8367-6377","authenticated-orcid":true,"given":"Anja","family":"Herrnreiter","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee (T.K., A.H., S.L.P., W.B.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Pfister","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee (T.K., A.H., S.L.P., W.B.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeniyi","family":"Adebesin","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas (A.A., J.R.F.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9219-7845","authenticated-orcid":true,"given":"John R.","family":"Falck","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas (A.A., J.R.F.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4361-1488","authenticated-orcid":true,"given":"William B.","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee (T.K., A.H., S.L.P., W.B.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.10.010"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000143628.37680.F6"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)62287-0"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01120.2011"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00473"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.01.010"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.034470"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17070797"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M300183-JLR200"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.05.008"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e328350261b"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2011.39"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.86.6.663"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(98)00610-4"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(01)00935-9"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2008.11.003"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01135.2010"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199001000-00012"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000112225.27560.24"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemphyslip.2003.09.016"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.34.4.983"},{"key":"e_1_3_2_23_2","first-page":"957","article-title":"The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha.","volume":"281","author":"Kinsella BT","year":"1997","unstructured":"Kinsella, BT, O\u2019Mahony, DJ, Fitzgerald, GA. The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha. J Pharmacol Exp Ther. 1997;281:957\u2013964.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M011361200"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-011-0995-y"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/apha.12642"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00114.2005"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.37.2.334"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.27.5.1149"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1086\/686311"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.30.635"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00821.2014"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M081448"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.36.3.312"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.29.3.796"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.216564"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00690.2012"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20072329"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1113\/JP272065"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00040.2005"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1993.265.6.F881"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10059-011-1021-7"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/hh0202.103615"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2012.04.015"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/1470320309347785"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12677"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.38.23185"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.121.17824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T06:31:03Z","timestamp":1715581863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.121.17824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.121.17824"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.121.17824","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"2021-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}